» Articles » PMID: 14651414

A Study of the Feasibility of Internet Administration of a Computerized Health Survey: the Headache Impact Test (HIT)

Overview
Journal Qual Life Res
Date 2003 Dec 4
PMID 14651414
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Headache impact test (HIT) is a precise, practical tool that quantifies the impact of headache on respondents' lives. It is the first widely-available dynamic health assessment (DynHA). Applications of this brief, precise survey include population based screening for disabling headaches, tracking of individual patient scores over time, disease management programs and others. We use data from Internet HIT assessments during the fall of 2000 to (1) evaluate characteristics of respondents and assessments, (2) assess the utility of joint administration of HIT and the SF-8 Health Survey (SF-8) to screen for migraine and depression, and (3) explore associations between HIT scores and subsequent healthcare-related attitudes and behaviors.

Methods: We analyzed Internet HIT surveys completed between 9/1 and 11/30/2000 (n = 19,195). Subsamples include respondents who also completed (1) a 12-item Internet survey assessing severity, frequency, cause and management of headaches; (2) an e-mail survey measuring healthcare-related behaviors; (3) the SF-8; or (4) the website registration process, providing age and gender data. We used analysis of variance (ANOVA) to evaluate HIT score differences associated with age, gender, headache severity or frequency, and healthcare-related behaviors and attitudes and chi2 tests to assess the prevalence and comorbidity of migraine and depression.

Results: Three-quarters of respondents achieved a precise HIT score in < or = 5 items. Most had moderate/severe headaches; 65% had headaches at least monthly. HIT scores were directly related to headache severity and frequency. Most respondents were females, with significantly higher HIT scores than males. Most HIT respondents were between ages 25 and 54 (HIT scores were higher for younger respondents). Sixty four percent screened positive for migraine; 20% for depression. Both conditions were more prevalent among females than males. Comorbid migraine and depression was 50% more prevalent among females and increased with age until age 50. Patients with worse headache impact were more likely to seek care, discuss headaches with their providers and find HIT useful.

Conclusions: It is feasible to use Internet-based dynamic assessments to measure health status. These data complement previous results showing that HIT differentiates respondents according to headache characteristics (severity and frequency). HIT plus SF-8 yields a practical screen for migraine and depression in headache patients and may lead to more effective treatment for patients with these conditions. Preliminary findings suggest that the experience of taking HIT on the Internet may motivate headache patients to seek care and discuss headaches with their providers.

Citing Articles

Comparison of Early-onset Efficacy of Anti-calcitonin Gene-related Peptide Monoclonal Antibodies for Patients with Migraine in Real-world Clinical Practice: Study Protocol for an Exploratory Clinical Trial.

Tanei T, Maesawa S, Nishimura Y, Ishizaki T, Nagashima Y, Hashida M Neurol Med Chir (Tokyo). 2024; 65(2):71-80.

PMID: 39662907 PMC: 11891144. DOI: 10.2176/jns-nmc.2024-0201.


Morphological similarity and white matter structural mapping of new daily persistent headache: a structural connectivity and tract-specific study.

Zhang D, Zong F, Mei Y, Zhao K, Qiu D, Xiong Z J Headache Pain. 2024; 25(1):191.

PMID: 39497095 PMC: 11533401. DOI: 10.1186/s10194-024-01899-9.


Predictors of Headaches and Quality of Life in Women with Ophthalmologically Resolved Idiopathic Intracranial Hypertension.

Horev A, Aharoni-Bar S, Katson M, Tsumi E, Regev T, Zlotnik Y J Clin Med. 2024; 13(13).

PMID: 38999535 PMC: 11242489. DOI: 10.3390/jcm13133971.


The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session.

Ilgaz Aydinlar E, Erdogan Soyukibar T, Yalinay Dikmen P Front Neurol. 2024; 15:1417303.

PMID: 38962481 PMC: 11219632. DOI: 10.3389/fneur.2024.1417303.


Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine.

Ilgaz Aydinlar E, Erdogan Soyukibar T, Yalinay Dikmen P Front Neurol. 2024; 15:1411238.

PMID: 38887386 PMC: 11180826. DOI: 10.3389/fneur.2024.1411238.


References
1.
Bjorner J, Kosinski M, Ware Jr J . Calibration of an item pool for assessing the burden of headaches: an application of item response theory to the headache impact test (HIT). Qual Life Res. 2003; 12(8):913-33. DOI: 10.1023/a:1026163113446. View

2.
Breslau N, Davis G . Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia. 1992; 12(2):85-90. DOI: 10.1046/j.1468-2982.1992.1202085.x. View

3.
Ware Jr J, Bjorner J, Kosinski M . Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales. Med Care. 2000; 38(9 Suppl):II73-82. View

4.
Berwick D, Murphy J, Goldman P, Ware Jr J, Barsky A, Weinstein M . Performance of a five-item mental health screening test. Med Care. 1991; 29(2):169-76. DOI: 10.1097/00005650-199102000-00008. View

5.
Merikangas K, Angst J, Isler H . Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry. 1990; 47(9):849-53. DOI: 10.1001/archpsyc.1990.01810210057008. View